Valeo Pharma (TSE:VPH) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Valeo Pharma Inc., a Canadian pharmaceutical firm, is delisting its Class A shares from the OTCQB Venture Market due to low trading volume and high costs, focusing instead on the TSX and FSE markets. This strategic move, aimed to consolidate trading platforms, was announced by CEO Al Moghaddam, highlighting the TSX’s senior status and advanced trading system.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.